Table 1 Clinical characteristics of patients with hyperlipidemic severe acute pancreatitis
From: Analysis of the clinical profile and treatment efficiency of hyperlipidemic acute pancreatitis
Characteristic | All(N = 127) |
|---|---|
Age,yr | 37.1 ± 8.7 |
Sex, n(%) | |
Male | 89(70.1) |
Female | 38(29.9) |
BMI, kg/m2 | 27.8 ± 3.3 |
Complications, n(%) | |
Diabetes | 66(52.0) |
Fatty liver | 106(83.5) |
Hypertensive | 62(48.8) |
Recurrence, n(%) | 42(33.1) |
APACHE II | 14.9 ± 6.2 |
CTSI | 5.1 ± 0.9 |
Ranson | 3.72 ± 1.4 |
Organ failure, n(%) | 61(48.0) |
Treatment, n(%) | |
Standard treatment | 53(41.7) |
PE | 74(58.3) |
ERCP | 55(43.3) |
Baseline TG,mmol/L | 28.25 ± 13.28 |
Baseline AMY, U/L > 110U/L,n(%) | 539.94 ± 418.00 107(84.3) |
> 330U/L,n(%) | 60(47.2) |
Admission to ICU,n(%) | 70(55.1) |
Medical costs,CNY | 64920.73 ± 68965.56 |
Length of hospital, d | 22.5 ± 6.6 |
Death, n(%) | 27(21.3) |